U.S. stocks rebounded strongly on Thursday as shareholders digested a batch of generally positive economic reports.
The Dow Jones Industrial Average jumped 254.69 points, or 1.07 percent, to 24,103.11. The S&P 500 raised 35.87 points, or 1.38 percent, to 2,640.87. The Nasdaq Composite Index was up 114.22 points, or 1.64 percent, to 7,063.45.
In the week ending March 24, the advance figure for seasonally adjusted initial claims for state unemployment benefits was 215,000, a decrease of 12,000 from the previous week’s revised level, the U.S. Labor Department declared Thursday. This is the lowest level for initial claims since Jan. 27, 1973 when it was 214,000.
The four-week moving average was 224,500, a decrease of 500 from the previous week’s revised average.
The final reading of U.S. Consumer Sentiment Index came in at 101.4 in March, marking the highest level since 2004, according to a survey released by the University of Michigan on Thursday.
Meanwhile, U.S. personal income raised 67.3 billion U.S. dollars, or 0.4 percent, in February, while personal consumption expenditures raised 27.7 billion dollars, or 0.2 percent, the Commerce Department said Thursday. Both figures are on par with market consensus.
“Consumer spending spiked in September and remained strong before the holidays, but has been anemic since. It’s entirely possible – likely, even – consumption will recover now that the saving rate has risen a percentage point from its recent low,” said Chris Low, chief economist at FTN Financial, in a note.
U.S. stock markets will be closed on Friday because of the Good Friday holiday.
For the holiday-shortened week, all three major indices posted solid gains, with the Dow, the S&P 500 and the Nasdaq jumping 2.4 percent, 2.0 percent and 1.0 percent, respectively. (Source: Xinhua)
Top Pick for Friday: Global Blood Therapeutics Inc (NASDAQ: GBT)
Global Blood Therapeutics Inc (NASDAQ: GBT) has grabbed attention from the analysts when it experienced a change of 1.26% in the last trading session to close at $48.30. A total of 929,945 shares exchanged hands during the intra-day trade contrast with its average trading volume of 1.11M shares, while its relative volume stands at 0.84. Relative volume is the comparison of current volume to average volume for the same time of day, and it’s displayed as a ratio. If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it. If RVOL is above 2 it is In Play and this is more evidence Investors ought to be in the name. When stocks are *very* In Play one can see a RVOL of 5 and above. The higher the RVOL the more In Play the stock is.
Day traders strive to make money by exploiting minute price movements in individual assets (usually stocks, though currencies, futures, and options are traded as well), usually leveraging large amounts of capital to do so, therefore they trade on Stocks in Play. In Play Stocks are volatile enough to produce good risk and reward trading opportunities for both bull and bear traders intraday. Most company stocks have very little volatility. They generally move extremely slowly and they only produce big price swings when the company produces good or bad trading results, which may only happen a couple of times a year at best.
In deciding what to focus on – in a stock, say – a typical day trader looks for three things: liquidity, volatility and trading volume. Liquidity allows an investor to enter and exit a stock at a good price (i.e. tight spreads, or the difference between the bid and ask price of a stock, and low slippage, or the difference between the predictable price of a trade and the actual price). If a stock does not have good liquidity then it may take some time before a broker is able to negotiate a deal to buy or sell a stock and the broker may not be able to get the sell or buy price that the trader is looking for. This is a problem for day traders and it could mean the difference between a profitable and non-profitable trade.
Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. 100,000 shares traded per day would be a minimum for most traders and some require 1,000,000.
Trading volume is a gauge of how many times a stock is bought and sold in a given time period (most commonly, within a day of trading, known as the average daily trading volume – ADTV). A high degree of volume indicates a lot of interest in a stock. Often, a boost in the volume of a stock is a harbinger of a price jump, either up or down.
Volatility is simply a measure of the predictable daily price range—the range in which a day trader operates. More volatility means greater profit or loss. After a recent check, Global Blood Therapeutics Inc (NASDAQ: GBT) stock is found to be 5.96% volatile for the week, while 5.36% volatility is recorded for the month.
The stock has a market cap of $2.32B and the number of outstanding shares has been calculated 48.09M. Based on a recent bid, its distance from 20 days simple moving average is -11.05%, and its distance from 50 days simple moving average is -16.13% while it has a distance of 22.64% from the 200 days simple moving average. The company’s distance from 52-week high price is -29.02% and the current price is 101.04% away from 52-week low price. The company has Relative Strength Index (RSI 14) of 34.81 together with Average True Range (ATR 14) of 2.89.
Past 5 years growth of GBT observed at N/A, and for the next five years the analysts that follow this company is expecting its growth at 37.00%. The stock’s price to sales ratio for trailing twelve months is N/A and price to book ratio for the most recent quarter is 6.63, whereas price to cash per share for the most recent quarter are 7.38. Its quick ratio for the most recent quarter is 12.30. Analysts mean recommendation for the stock is 1.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Disclaimer: Any news, report, research, and analysis published on Alphabetastock.com are only for information purposes. Alpha Beta Stock (ABS) makes sure to keep the information up to date and correct, but we didn’t suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. Information in this release is fact checked and produced by competent editors of Alpha Beta Stock; however, human error can exist.
This post was originally published on *this site*